Autolus Therapeutics plc American Depositary Share

Last updated September 27, 2026

Organization details

Legal name
Autolus Therapeutics plc American Depositary Share
Former names
Autolus Therapeutics Ltd
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Year founded
2018
Jurisdiction of incorporation
United Kingdom
Headquarters city
London
Headquarters country
United Kingdom
Fiscal year end
December
Ticker symbol
AUTL
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001730463
UK company number
11185179
Wikidata ID
Q56583577

Board of directors

Former directors

Chief executives

Christian Itin · Chief Executive Officer
Since March 2026

Board connections

6 of this board's directors also sit on 12 other boards. 12 are in the same sector.

Network of Autolus Therapeutics plc American Depositary Share's board connections ADC Therapeutics SA ADC Therapeutics SA Alnylam Pharmaceuticals Inc. Alnylam Pharmaceutical... Arvinas Inc. Arvinas Inc. Cardinal Health Inc. Cardinal Health Inc. Century Therapeutics Inc. Century Therapeutics I... Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... Immunic Inc. Immunic Inc. Olema Pharmaceuticals Inc. Olema Pharmaceuticals... Pliant Therapeutics Inc. Pliant Therapeutics In... Praxis Precision Medicines Inc. Praxis Precision Medic... Tango Therapeutics Inc. Tango Therapeutics Inc... UroGen Pharma Ltd. UroGen Pharma Ltd. Cynthia M. Butitta Cynthia M. Butitta Linda Bain Linda Bain Michael W. Bonney Michael W. Bonney Robert Azelby Robert Azelby Robert Iannone Robert Iannone William D. Young William D. Young Autolus Therapeutics plc A...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$15,708
1 sale by 1 insider
Date Insider Transaction Shares Price Value
Sep 2, 2026 Piccina Cintia Officer (U.S. CCO & Country Gen Manager) Open-market sale −6,713 $2.34 $15,708
Sep 1, 2026 Piccina Cintia Officer (U.S. CCO & Country Gen Manager) Option exercise +20,000 $2.35 $47,000

Organizations in the same sector, closest in location and size first.

Questions about Autolus Therapeutics plc American Depositary Share

Who is the CEO of Autolus Therapeutics plc American Depositary Share?

Christian Itin has been Autolus Therapeutics plc American Depositary Share's Chief Executive Officer since March 2026.

How many directors are on Autolus Therapeutics plc American Depositary Share's board?

Autolus Therapeutics plc American Depositary Share's board has 22 directors: Christian Itin, Christian Martin Itin, Cynthia M. Butitta, Cynthia Marie Butitta, Elisabeth Leiderman, Elisabeth Pamela Leiderman, John E. Berriman, Linda Bain, Linda Catharina Bain, Madduri Ravin Rao and 12 others.

Are Autolus Therapeutics plc American Depositary Share insiders buying or selling shares?

Over the last 12 months, Autolus Therapeutics plc American Depositary Share insiders made no open-market purchases and sold $15,708 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="autolus-therapeutics-plc-american-depositary-share"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.